Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Sets New 1-Year High at $9.55

Fresenius SE & Co. KGaA (OTCMKTS:FSNUYGet Free Report) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $9.55 and last traded at $9.43, with a volume of 19301 shares traded. The stock had previously closed at $9.35.

Fresenius SE & Co. KGaA Stock Down 0.5 %

The company has a 50 day moving average of $8.70 and a 200 day moving average of $7.84.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUYGet Free Report) last released its earnings results on Wednesday, July 31st. The company reported $0.22 EPS for the quarter. The business had revenue of $5.83 billion for the quarter. Analysts forecast that Fresenius SE & Co. KGaA will post 0.82 EPS for the current year.

Fresenius SE & Co. KGaA Company Profile

(Get Free Report)

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

See Also

Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.